Convenzione: update on the proposals received following the first level consultation
The Technical Committee (TC) as foreseen by the Convenzione signed on 30 December 2020 between the Ministry of University and Research, the Ministry of Health and the Ministry of Economy and Finance and the Human Technopole Foundation (HT) informs that 29 National Facilities were proposed by the national scientific community as part of the first level consultation, provided for by the Convenzione.
This first phase of the process, as illustrated in the attached communication by the Technical Committee, saw the involvement of 167 institutional stakeholders representing universities, research hospitals (IRCCS), research centres, funding organisations and the life science industry as identified by the Committee.
These stakeholders were invited to contribute to the identification of a first set of priority facilities in high demand by the national life sciences community. A total of 60 questionnaires were submitted, 48 with initiatives supported by several institutes and 12 from single institutes.
The 29 proposed National Facilities are currently being evaluated by the Technical Committee. Following this evaluation, a second level consultation will begin aimed at the entire scientific community and key players of society by providing them with the list of potential platforms of national interest.
Once the second level consultation will have been completed, the Technical Committee will draft a final report for Human Technopole and the involved Ministries to share the results of the consultations and the indication, in order of priority, of the Facilities in highest demand by the national scientific community.
The Convenzione of 30 December 2020, which implemented the 2020 Budget Law, further enhances HT’s efforts to create a scientific hub to support research in Italy with high level infrastructures and skills, to be built together with interested scientific communities and open on a competitive basis to all Italian researchers, independently of their institutional affiliation.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.